Overview Lung Deposition Via Different Inhalation Devices Status: Completed Trial end date: 2009-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the deposition of budesonide to the lung after inhalation with 5 different devices and to relate the findings to in vitro properties of inhaled budesonide. Phase: Phase 1 Details Lead Sponsor: AstraZenecaTreatments: Budesonide